Rifaximin: Exploring Global Pricing Inequities and Access Obstacles Rifaximin, an antibiotic with minimal absorption, is an essential treatment for various gastrointestinal disorders, including irritable bowel syndrome with diarrhea (IBS-D) and
Rifaximin: Exploring Global Pricing Inequities and Access Obstacles Rifaximin, an antibiotic with minimal absorption, is an essential treatment for various gastrointestinal disorders, including irritable bowel syndrome with diarrhea (IBS-D) and